期刊文献+

前B急性淋巴细胞白血病细胞Sup-B15对化疗药物敏感性及侵袭力的研究 被引量:1

Chemosensitivity and angiogenic potency of pre-B acute lymphoblastic leukemia cell line Sup-B15
原文传递
导出
摘要 目的 探讨Ik6阳性表达的前B急性淋巴细胞白血病细胞Sup-B15对化疗药物的敏感性及侵袭力,并与国内常用的细胞模型Nalm-6进行比较研究.方法 采用巢式反转录-PCR及Western blot法检测细胞Ik6的表达;应用CCK-8法检测化疗药物长春新碱(VCR)、柔红霉素(DNR)、左旋门冬酰胺酶(L-Asp)及地塞米松(Dex)对细胞增殖的影响;采用Transwell小室检测细胞的迁移和侵袭力;应用实时荧光定量PCR法检测血管新生相关基因VEGF、Flt-1、PlGF、Ang1、Ang2和IGF-1的表达.结果 Nalm-6细胞中未检测到Ik6的表达.相比较于Nalm-6细胞,Sup-B15细胞生长速度较慢.4种化疗药物均能以时间和剂量依赖方式抑制两细胞的增殖,Sup-B15细胞对DNR、L-Asp和Dex更敏感,IC50分别是Nalm-6细胞的9.5倍、1.1倍和1.5倍,但是对VCR的敏感性不及Nalm-6细胞.Transwell小室实验显示迁移或侵袭到下室的Sup-B15细胞较少.血管新生相关基因在Sup-B15细胞中相对低表达.结论 Sup-B15细胞相比较于Nalm-6细胞,是一种对化疗药物更敏感、侵袭力较弱的前B急性淋巴细胞系. Objective It has been reported that Ik6 overexpression is associated with poor outcome of childhood pre-B acute lymphoblastic leukemia and Sup-B15 cell line is Ik6 positive.There were fewer studies on the Sup-B15 in the country,so the aim of this research is to explore chemosensitivity and angiogenic potency of pre-B acute lymphoblastic leukemia cell line Sup-B15 associated with Ik6 positive expression through making a comparison between Sup-B15 and Nalm-6 cell line.Methods The Ik6 mRNA and protein expression were detected by nested reverse transcription polymearse chain reaction and Western blot.The effect of vincristine,daunorubicin,L-asparaginase and dexamethasone on the proliferation of cells was measured by using CCK-8 assay.The migration and invasion of cells were detected by transwell assay and mRNA expression of angiogenesis genes (VEGF,Flt-1,PlGF,IGF-1,Ang1 and Ang2) was measured by real-time PCR.Results No expression of Ik6 was detected in Nalm-6 cell line.Compared with Nalm-6,Sup-B15 cell line had a lower rate of growth.The 4 drugs could inhibit the proliferation of cells in a dose-and time-depen-dence manner.Sup-B15 was more sensitive to daunorubicin,L-asparaginase and dexamethasone,and the folds of respective IC50 value were 9.5,1.1 and 1.5.But Sup-B15 was more resistant to vincristine than Nalm-6.The result of transwell assay showed that less Sup-B15 cells transmigrated to the lower chamber.A significant lower expression level of angiogenesis genes was detected in Sup-B15 cells.Conclusion These findings suggest that Sup-B15 is more sensitive to chemotherapy and less angiogenic compared with Nalm-6.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2014年第3期186-189,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(81300414)
关键词 Sup-B15 Nalm-6 化疗敏感性 侵袭力 Sup-B15 Nalm-6 Chemosensitivity Invasiveness
  • 相关文献

参考文献16

  • 1Mullighan CG,Su X,Zhang J. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia[J].New England Journal of Medicine,2009,(05):470-480.
  • 2Mullighan CG,Miller CB,Phillips LA. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros[J].NATURE,2008,(7191):110-114.
  • 3Tonnelle C,Imbert MC,Sainty D. Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen[J].The Hematology Journal,2003,(02):104-109.
  • 4Ezzat S,Zhu X,Loeper S. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells[J].Molecular Endocrinology,2006,(11):2976-2986.
  • 5Iacobucci I,Lonetti A,Messa F. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors:implications for a new mechanism of resistance[J].Blood,2008,(09):3847-3855.
  • 6赵斌,葛金芳,朱娟娟,黄晓晖,李俊.小议在MTT法测细胞增殖抑制率中IC_(50)的计算方法[J].安徽医药,2007,11(9):834-836. 被引量:165
  • 7Meleshko AN,Movchan LV,Belevtsev MV. Relative expression of different Ikaros isoforms in childhood acute leukemia[J].Blood Cells, Molecules and Diseases,2008,(03):278-283.
  • 8Iacobucci I,Lonetti A,Cilloni D. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method[J].HAEMATOLOGICA,2008,(12):1814-1821.
  • 9Koipally J,Georgopoulos K. Molecular dissection of the repression circuitry of Ikaros[J].Journal of Biological Chemistry,2002,(31):27697-27705.
  • 10刘加军,张俊峰,林东军,陆敏强.冬凌草甲素对Nalm-6细胞的增殖抑制作用及其作用机制[J].中华肿瘤防治杂志,2009,16(13):966-969. 被引量:9

二级参考文献16

  • 1李保华,董向丽,孙显明,赵川德,才秀华,孙立宁.用于计算半数致死量(LD50)的SAS程序[J].莱阳农学院学报,2004,21(4):269-274. 被引量:10
  • 2张俊峰,陈规划,陆敏强,蔡常洁,杨扬,李华.冬凌草甲素对人肝癌BEL-7402细胞的增殖抑制作用研究[J].中华肿瘤防治杂志,2006,13(15):1131-1133. 被引量:8
  • 3Guang-Biao Zhou,Sai-Juan Chen,Zhen-Yi Wang,Zhu Chen.Back to the future of oridonin: again,compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo[J].Cell Research,2007,17(4):274-276. 被引量:10
  • 4司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 5刘昌孝 孙瑞元.药物评价实验设计与统计学基础[M].北京:军事医学科学出版社,2001,4.84-88.
  • 6RI弗雷谢尼,动物细胞培养基本技术指南(分子克隆实验指南系列)[M].第4版.北京:科学出版社,2004:398-400.
  • 7Yam J,Reer PJ,Bruce RD.Comparison of the up-and-down method and the fixed-dose procedure for acute oral toxicity testing[M].Food Chem Toxicol.ENGLAND.1991:259-63.
  • 8Van den Heuvel MJ,Clark DG,Fielder RJ.et al.The international validation of a fixed-dose procedure as an alternative to the classical LD50 test[M1].Food Chem Toxicol.ENGLAND,1990:469-82.
  • 9Halle W.The Registry of Cytotoxicity:toxicity testing in cell cultures to predict acute toxicity(LD50)and to reduce testing in animals[M].Altern Lab Anim.England,2003:89-198.
  • 10Schlede E,Genschow E,Spielmann H,et al.Oral acute toxic class method:a successful alternative to the oral LD50 test[M].Regul Toxicol Pharmacol.United States,2005:15-23.

共引文献173

同被引文献18

  • 1Guler T,Cakmak OY,Toprak SK,et al.Inlrathecal methotrexate-induced posterior reversible encephalopathy syndrome(PRES)[J].Turk J Haematol,2014,31(1):109-110.
  • 2Apuri S,Carlin K,Bass E,et al.Tacrolimus associated posterior reversi- ble encephalopathy syndrome-a case series and review[J].Mediterr J Hematol Infect Dis,2014,6(1):e2014014.
  • 3Belaramani KM,Lai V,Li CH,et al.Reversible posterior leukoencepha- lopathy syndrome in Chinese children induced by chemotherapy:a re- view of five cases[J].Hong Kong Med J,2011,17(1):61-66.
  • 4Tsukamoto S,Takeuchi M,Kawajiri C,et al.Posterior reversible ence- phalopathy syndrome in an adult patient with acute lymphoblastic leuke- mia after remission induction chemotherapy[J].Int J Hematol,2012,95(2):204-208.
  • 5Watsky MA,Carbone LD,An Q,et al.Bone turnover in long-term survi- vors of childhood acute lymphoblastic leukemia[J].Pediatr Blood Cancer,2014,61(8):1451-1456.
  • 6Kembhavi SA,Somvanshi S,Banavali S,et al.Pictorial essay:acute neu- rological complications in children with acute lymphoblastic leukemia[J].Indian J Radiol Imaging,2012,22(2):98-105.
  • 7Kim SJ,Im SA,Lee JW,et al.Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia[J].Pediatr Neurol,2012,47(6):436-442.
  • 8Graham BR,Pylypchuk GB.Posterior reversible encephalopathy syn- drome in an adult patient undergoing peritoneal dialysis:a case report and literature review[J].BMC Nephrol,2014,15(1):10.
  • 9Subspecialty Group of Hematology Diseases.The society of pediatrics, Chinese medical association;editorial board,Chinese journal of pediat- rics.Recommendations for diagnosis and treatment of acute lympho- blastic leukemia in childhood(3rd revised version)[J].Zhonghua Er Ke Za Zhi,2006,44(5):392-395.
  • 10Singh RR,Ozyilmaz N,Waller S,et al.A study on clinical and radio- logical features and outcome in patients with posterior reversible en- cephalopathy syndrome(PRES)[J].Eur J Pediatr,2014,173(9):1225-1231.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部